Pure red cell aplasia

British Journal of Haematology

Volumn 111, Issue 4, 2000, Pages 1010-1022

  Fisch, Paul ^a   Handgretinger, Rupert ^b   Schaefer, Hans Eckart ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Diamond Blackfan anaemia; Large granular lymphocytes; Parvovirus B19; Pure red cell aplasia; T lymphocytes

Indexed keywords

BLACKFAN DIAMOND ANEMIA; BONE MARROW BIOPSY; CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; MYELODYSPLASIA; NATURAL KILLER CELL; PARVOVIRUS; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

ANTICONVULSANTS; ANTITUBERCULAR AGENTS; AUTOIMMUNE DISEASES; AZATHIOPRINE; BONE MARROW CELLS; FANCONI ANEMIA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; ISONIAZID; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOCYTIC; MALE; PARVOVIRUS B19, HUMAN; PHENYTOIN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RED-CELL APLASIA, PURE; T-LYMPHOCYTES;

EID: 0034486505     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02429.x     Document Type: Review

References (127)

1. Pure red cell aplasia: Lymphocyte inhibition of erythropoiesis
2. Lymphocytes and antibody in retrovirus-induced feline pure red cell aplasia
3. Pure red cell aplasia and thymoma: Loss of serum inhibitor of erythropoiesis following thymectomy
4. Thumbs and anemia
5. Red cell aplasia in children
6. Acquired pure red cell aplasia
7. In vitro growth and regulation of bone marrow enriched CD34+ hematopoietic progenitors in Diamond-Blackfan anemia
8. Pure red cell aplasia of pregnancy: A distinct clinical entity
9. Diamond-Blackfan anaemia in the U.K. analysis of 80 cases from a 20-year birth cohort
10. Parvovirus B19 infection and hematopoiesis
11. Parvovirus B19 in human disease
12. Congenital anaemia after transplacental B19 parvovirus infection
13. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia
14. Erythroid aplasia in systemic lupus erythematosus
15. Diamond-Blackfan syndrome. I. Erythropoiesis in prednisone responsive and resistant disease
16. Diamond-Blackfan syndrome. II. In vitro corticosteroid effect on erythropoiesis
17. The pathophysiology of pure red cell aplasia: Implications for therapy
18. Transient erythroblastopenia of childhood. Prospective study of fifty patients
19. Pure red-cell aplasia in patients with chronic lymphocytic leukemia
20. Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients
21. Parvovirus-like particles in human sera
22. Humoral suppression of erythropoiesis in systemic lupus erythematosus (SLE) and rheumatoid arthritis
23. The events in the hemolytic crisis of hereditary spherocytosis, with particular reference to the reticulocytopenia, pancytopenia and an abnormal splenic mechanism
24. Regulation of T-cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles
25. Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus
26. Studies on pure red cell aplasia. X. Association with acute leukemia and significance of bone marrow karyotype abnormalities
27. Rheumatoid arthritis and pure red cell aplasia
28. Diphenylhydantoin-induced pure red cell aplasia
29. Congenital hypoplastic anemia: Diamond-Blackfan syndrome. Historical and clinical aspects
30. Hypoplastic anemia
31. Congenital hypoplastic anemia
32. Mutations in the erythropoietin receptor gene are not a common cause of Diamond-Blackfan anemia
33. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia
34. Treatment of Diamond-Blackfan anaemia with haematopoietic growth factors, granulocyte-macrophage colony stimulating factor and interleukin 3: Sustained remissions following IL-3
35. Splenectomy for "pure red cell" hypoplastic (aregenerative) anemia associated with autoimmune hemolytic disease
36. Pure red blood cell aplasia associated with parvovirus B19 infection in large granular lymphocyte leukemia
37. Marrow-suppressing factors in the blood in pure red-cell aplasia, thymoma and Hodgkin's disease
38. Corticosteroid-responsive acquired pure red cell aplasia in adults
39. Inhibitory MHC class I receptors on γδ T cells in tumour immunity and autoimmunity
40. A quest for erythropoietin over nine decades
41. Transient erythroblastopenia of childhood with CD10, TdT, and cytoplasmic μ lymphocyte positivity in bone marrow
42. Pure red cell aplasia in childhood and adolescence: Pathogenesis and approaches to diagnosis
43. Diamond-Blackfan syndrome: Evidence against cell-mediated erythropoietic suppression
44. Erythroid colony growth in congenital hypoplastic anemia
45. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia
46. Myelodysplastic syndrome with erythroid hypoplasia/aplasia: A case report and review of the literature
47. Erythroblastopénie aigue dans les anémies hémolytiques
48. Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia
49. Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia
50. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation
51. Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome)
52. Transient erythroblastopenia of childhood presenting with papilledema
53. Diamond-Blackfan anaemia in a girl with a de novo balanced reciprocal X;19 translocation
54. Diamond-Blackfan anaemia: Genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 Mb
55. Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity
56. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors
57. Die hämolytischen anämien
58. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin
59. Diamond-Blackfan syndrome: Lymphocyte-mediated suppression of erythropoiesis
60. T-cell chronic lymphocytic leukemia: Presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro
61. Familial crises in congenital haemolytic disease
62. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
63. Benign thymoma and selective erythroid aplasia of the bone marrow
64. Diamond-Blackfan anemia. Natural history and sequelae of treatment
65. Panhypoplasia of the bone marrow. I. Demonstration of a plasma factor with antierythropoietin-like activity
66. Anemia of infancy and early childhood
67. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity
68. Zur entstehung der blutplättchen
69. Dyserythropoiesis and erythroblast-phagocytosis preceding pure red cell aplasia
70. Anaemias of marasmus and kwashiorkor in Kenya
71. Erythroid aplasia in riboflavin-deficient baboons and its relation to marasmus and kwashiorkor
72. Annotation: Pure red cell aplasia
73. Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei
74. Studies on red cell aplasia. II. Report of a second patient with an antibody to erythroblast nuclei and a remission after immunosuppressive therapy
75. Human parvovirus B19-induced aplastic crisis in iron deficiency anemia
76. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy
77. Transient erythroblastopenia of childhood. Review of 17 cases, including a pair of identical twins
78. Pure red cell aplasia: Association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities
79. Human T-cell leukemia virus-I-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T γ-lymphoproliferative disease
80. Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man
81. Regulation of immune responses through inhibitory receptors
82. Clonal diseases of large granular lymphocytes
83. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature
84. Induction of NK activity in large granular lymphocyte leukemia: Activation with anti-CD3 monoclonal antibody and interleukin 2
85. T-cell clonality in immune responses
86. Tγ (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia
87. Pure red cell aplasia (PRCA): Response of three patients of cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis
88. Diamond-Blackfan anaemia: Three patterns of in vitro response to haemopoietic growth factors
89. Control of antibody-mediated pure red-cell aplasia by plasmapheresis
90. Über eine hereditäre, unter dem bilde eines chronischen icterus mit urobilinurie. Splenomegalie und nierensiderosis verlaufende affection
91. Pure red cell aplasia and carcinoma
92. Hodgkin disease and red cell aplasia
93. Pure red cell aplasia and hypogammaglobulinemia associated with Tγ-cell chronic lymphocytic leukemia
94. Clonal studies of CD3-lymphoproliferative disease of granular lymphocytes
95. Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia
96. Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro
97. Successful treatment of acquired myelofibrosis with pure red cell aplasia by cyclosporine
98. Treatment trial with recombinant human erythropoietin in children with congenital hypoplastic anemia
99. Congenital hemolytic jaundice. The pathogenesis of the "hemolytic crises"
100. Acquired pure red-cell aplasia: A consequence of increased natural killer cell activity?
101. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia
102. Pure red cell aplasia: Studies on an IgG serum inhibitor neutralizing erythropoietin
103. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
104. Relapsing pure red-cell aplasia during pregnancy
105. Preleukemic states
106. T-cell recognition of non-peptide antigens
107. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19)
108. Pure red cell aplasia in rheumatoid arthritis
109. Reduced neutrophil counts in children with transient erythroblastopenia of childhood
110. The syndrome of benign thymoma and primary aregenerative anemia
111. Long-term bone marrow cultures in Diamond-Blackfan anemia reveal a defect of both granulomacrophage and erythroid progenitors
112. Aplastic crisis in haemolytic anaemia due to infection parvovirus B19
113. Disorders of large granular lymphocytes and natural killer-associated cells
114. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent
115. Transient erythroblastopenia of childhood in Sweden: Incidence and findings at the time of diagnosis
116. Transient red cell aplasia in siblings: A common environmental or a common hereditary factor?
117. Pure red cell aplasia in cats: 9 cases (1989-97)
118. Chromosome abnormality and hypocalcemia in congenital erythroid hypoplasia. (Blackfan-Diamond syndrome)
119. Chronic natural killer cell lymphocytosis: A descriptive clinical study
120. Drug-induced pure red cell aplasia
121. An intrinsic progenitor defect in Diamond-Blackfan anaemia
122. Transient erythroblastopenia in the first year of life
123. Diamond-Blackfan anemia
124. Biochemical lesion in Dilantin-induced erythroid aplasia
125. Studies on pure red cell aplasia. VI. Development of two-stage erythroblast cytotoxicity method and role of complement
126. Studies on pure red cell aplasia. VII. Presence of proerythroblasts and response to splenectomy: A case report
127. The role of thymectomy in red cell aplasia